More than 1,000 genes may serve as possible treatment targets for individuals with kidney disease, according to a new study, ...

These and other GLP1-RA diabetes/weight-loss meds can also boost outcomes for folks battling chronic kidney disease, new ...

In adults with cystic fibrosis, gastrointestinal symptoms initially improve with ETI but most do not consistently improve with longer-term use.

Over 1,000 genes may serve as possible treatment targets for individuals with kidney disease, according to a new study, published in Science, from researchers at the Perelman School of Medicine at the ...

A well-known class of drugs used to manage type 2 diabetes and control weight could offer hope for patients who also struggle ...

And if we use senolytics, we see that the inflammation goes away and the regenerative capacity of the surrounding tissue is restored — well, at least if you’re a mouse.” Based on dozens of preclinical ...

Learn how chronic kidney disease and diabetes accelerate heart risk, with new research revealing early warning signs.

Share and Cite: Hinz, B. and Kenyon, J. (2025) Getting to a Diagnosis: A Rare Case of TFE3 Translocation Renal Cell Carcinoma ...

The study reveals new evidence that reinforces the health consequences of exposure. Researchers identify troubling cause of ...

The first recipient of a gene-edited pig kidney died from cardiac causes 52 days after xenotransplantation. The world's first ...

A year after guidelines were revised to remove the use of race in eGFR, many labs and pathologists were still relying on the ...

Low doses of glucocorticoids added to immunosuppression yield no significant benefit for skin fibrosis in early diffuse ...